Abstract
Prostate cancer is the most common malignancy in men. For the development of potential anti-prostate cancer agents, a series of arylpiperazine derivatives was synthesized based on previous studies. The target compounds were synthesized via three-step reaction and their in vitro cytotoxic efficacies against a panel of three human prostate cancer cell lines (PC-3, LNCaP, and DU145) and one normal prostate epithelial cell line (WPMY-1) were evaluated by CCK-8 assay. The derivatives 6, 7, 8, 10, 11, 13, 16, 20, 21, 22 and 25 showed important cytotoxic actions against the individual tested cancer cell line with IC50 values <10 μM. The results showed that the o-substituted phenyl group derivatives and m-substituted phenyl group derivatives displayed improved cytotoxic activity against PC-3 cells.
Keywords: Synthesis, derivatives, prostate cancer, CCK-8 assay, cytotoxicity, structure-activity relationship.
Graphical Abstract
Letters in Organic Chemistry
Title:Synthesis and Biological Evaluation of Arylpiperazine Derivatives as Anticancer Agents
Volume: 15 Issue: 11
Author(s): Hong Chen, Zonglin Yang, Tao Sun, Jiangxiu Niu, Xiumei Tian*Mu Yuan*
Affiliation:
- School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou,China
- Pharmaceutical Research Center, Guangzhou Medical University, Guangzhou,China
Keywords: Synthesis, derivatives, prostate cancer, CCK-8 assay, cytotoxicity, structure-activity relationship.
Abstract: Prostate cancer is the most common malignancy in men. For the development of potential anti-prostate cancer agents, a series of arylpiperazine derivatives was synthesized based on previous studies. The target compounds were synthesized via three-step reaction and their in vitro cytotoxic efficacies against a panel of three human prostate cancer cell lines (PC-3, LNCaP, and DU145) and one normal prostate epithelial cell line (WPMY-1) were evaluated by CCK-8 assay. The derivatives 6, 7, 8, 10, 11, 13, 16, 20, 21, 22 and 25 showed important cytotoxic actions against the individual tested cancer cell line with IC50 values <10 μM. The results showed that the o-substituted phenyl group derivatives and m-substituted phenyl group derivatives displayed improved cytotoxic activity against PC-3 cells.
Export Options
About this article
Cite this article as:
Chen Hong , Yang Zonglin , Sun Tao , Niu Jiangxiu , Tian Xiumei *, Yuan Mu *, Synthesis and Biological Evaluation of Arylpiperazine Derivatives as Anticancer Agents, Letters in Organic Chemistry 2018; 15 (11) . https://dx.doi.org/10.2174/1570178615666180518103641
DOI https://dx.doi.org/10.2174/1570178615666180518103641 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Molecular Therapy Intervention Prospects in Prostate Cancer
Current Pharmaceutical Design BRAF Inhibitor Therapy for Melanoma, Thyroid and Colorectal Cancers: Development of Resistance and Future Prospects
Current Cancer Drug Targets Anaesthesia in Cancer Surgery: Can it Affect Cancer Survival?
Current Clinical Pharmacology Hyperprolactinemia Secondary to Pituitary Microadenoma Versus Haloperidol- A Diagnostic Enigma. A Case Report and Brief Review
Current Drug Safety Recent Innovations in Antibody-Mediated, Targeted Particulate Nanotechnology and Implications for Advanced Visualisation and Drug Delivery
Current Nanoscience Focused Microarray Analysis: Characterization of Phenomes by Gene Expression Profiling
Current Pharmacogenomics Wnt Signaling in Rhabdomyosarcoma – A Potential Targeted Therapy Option
Current Drug Targets Signal Transduction of Steroidogenic Hormones to the Adrenal and Gonadal Mitochondria and the Possibilities for Combating Lipoid Congenital Adrenal Hyperplasia
Current Signal Transduction Therapy Mechanism of Action and Therapeutic Potential of Novel Adamantyl Retinoid-Related Molecules
Current Cancer Therapy Reviews Potential of Alphavirus Vectors in the Treatment of Advanced Solid Tumors
Recent Patents on Anti-Cancer Drug Discovery Peptide and Non-peptide Antagonists Targeting Endothelin Receptors in Physiology and Pathology
Current Pharmaceutical Design Environmental Chemicals and Breast Cancer Risk – A Structural Chemistry Perspective
Current Medicinal Chemistry Recent Progress in the Development of ATP-Competitive and Allosteric Akt Kinase Inhibitors
Current Topics in Medicinal Chemistry Phosphotyrosine Phosphatases in Cancer Diagnostic and Treatment
Recent Patents on DNA & Gene Sequences Exploring Patterns of Epigenetic Information with Data Mining Techniques
Current Pharmaceutical Design Recent Patents in the Field of Radioprotector Development: Opportunities and Challenges
Recent Patents on Biotechnology Prospective Clinical Applications of CRF Peptide Antagonists
Current Molecular Pharmacology HR MAS MR Spectroscopy in Metabolic Characterization of Cancer
Current Topics in Medicinal Chemistry The Insulin-Like Growth Factor (IGF) Signaling Pathway: Strategies for Successful Therapeutic Tasks in Cancer Treatment
Current Cancer Therapy Reviews Inflammation, Oxidative Stress and Metabolic Syndrome: Dietary Modulation
Current Vascular Pharmacology